According to Aspen Pharmacare's latest financial reports the company's current earnings are NZ$2.47 Billion. In 2024 the company made an earning of NZ$0.55 Billion a decrease over its 2023 earnings that were of NZ$0.60 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | NZ$0.55 B | -9.41% |
2023 | NZ$0.60 B | -30.33% |
2022 | NZ$0.87 B | 20.18% |
2021 | NZ$0.72 B | 71.28% |
2020 | NZ$0.42 B | 45.91% |
2019 | NZ$0.29 B | -66.03% |
2018 | NZ$0.85 B | 2.18% |
2017 | NZ$0.83 B | 16.58% |
2016 | NZ$0.71 B | -22.16% |
2015 | NZ$0.92 B | -11.62% |
2014 | NZ$1.04 B | 32.23% |
2013 | NZ$0.79 B | 7.54% |
2012 | NZ$0.73 B | 4.55% |
2011 | NZ$0.70 B | 43.51% |
2010 | NZ$0.48 B | 28% |
2009 | NZ$0.38 B | 46.12% |
2008 | NZ$0.26 B | 3.56% |
2007 | NZ$0.25 B | 21.01% |
2006 | NZ$0.20 B | 102.69% |
2005 | NZ$0.10 B | -31.39% |
2004 | NZ$0.15 B | 40.76% |
2003 | NZ$0.10 B |